Yervoy (ipilimumab) - BMS
ABP 206 (nivolumab biosimilar) - Amgen
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
prednisone delayed-release tablet - Generic mfg.
sirolimus - Generic mfg.
Nivocad (nivolumab biosimilar) - Biocad
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (clinicaltrials.gov) - Oct 15, 2026 - P1/2 | N=16 | Recruiting | Sponsor: National Cancer Institute (NCI) | Trial completion date: Jan 2027 ➔ Aug 2027 | Trial primary completion date: Jan 2027 ➔ Aug 2027 
Trial completion date • Trial primary completion date • Basal Cell Carcinoma • Cutaneous Melanoma • Genetic Disorders • Melanoma • Merkel Cell Carcinoma • Oncology • Skin Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Skin Cancer • Transplantation • BRAF
http://clinicaltrials.gov/ct2/show/NCT05896839
 
Oct 15, 2026
 
Prev Next